{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:34:12Z","timestamp":1790278452292,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AR049722"],"award-info":[{"award-number":["R01 AR049722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P50 AR070604"],"award-info":[{"award-number":["P50 AR070604"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ymthe.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T01:01:09Z","timestamp":1547514069000},"page":"636-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart"],"prefix":"10.1016","volume":"27","author":[{"given":"Rui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.01.005_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases--a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.01.005_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.005_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.005_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0074-7696(08)60158-8","article-title":"Characteristics of skeletal muscle in mdx mutant mice","volume":"191","author":"De la Porte","year":"1999","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"5, Suppl","key":"10.1016\/j.ymthe.2019.01.005_bib7","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/00002060-199509001-00003","article-title":"Profiles of neuromuscular diseases. Duchenne muscular dystrophy","volume":"74","author":"McDonald","year":"1995","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.ymthe.2019.01.005_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne\u2019s muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib9","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","article-title":"Long-term benefit from prednisone therapy in Duchenne muscular dystrophy","volume":"41","author":"Fenichel","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.01.005_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.01.005_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neubiorev.2013.03.016","article-title":"Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review","volume":"37","author":"Snow","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2019.01.005_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1469-8749.1968.tb02974.x","article-title":"The genetic relationship of progressive muscular dystrophy (Duchenne type) and mental retardation","volume":"10","author":"Cohen","year":"1968","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2015.01.023","article-title":"A possible role of dystrophin in neuronal excitability: a review of the current literature","volume":"51","author":"Hendriksen","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2019.01.005_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.01.005_bib16","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","article-title":"Cardiac involvement in Duchenne and Becker muscular dystrophy","volume":"7","author":"Mavrogeni","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib18","first-page":"657","article-title":"Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period","volume":"244","author":"Hoogerwaard","year":"1997","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nmd.2008.11.015","article-title":"Mammalian animal models for Duchenne muscular dystrophy","volume":"19","author":"Willmann","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.01.005_bib20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2019.01.005_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.01.005_bib22","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.01.005_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.12.009","article-title":"Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies","volume":"58","author":"Shirokova","year":"2013","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib24","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules20058823","article-title":"Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"20","author":"van Westering","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2019.01.005_bib25","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00448.2005","article-title":"Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice","volume":"289","author":"Janssen","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.005_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.005_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","article-title":"AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy","volume":"53","author":"Bostick","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","article-title":"Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice","volume":"17","author":"Bostick","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex\u00a0vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.01.005_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/hum.2008.058","article-title":"Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice","volume":"19","author":"Bostick","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib34","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib35","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1038\/srep08986","article-title":"Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice","volume":"5","author":"Betts","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.005_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cvr\/cvp335","article-title":"Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers","volume":"85","author":"Jearawiriyapaisarn","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2019.01.005_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mt.2009.248","article-title":"Prevention of dystrophic pathology in severely affected dystrophin\/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping","volume":"18","author":"Goyenvalle","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/gt.2009.120","article-title":"Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino","volume":"17","author":"Wu","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/hmg\/ddh174","article-title":"Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice","volume":"13","author":"Yue","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.01.005_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2014.01.009","article-title":"Low dystrophin levels in heart can delay heart failure in mdx mice","volume":"69","author":"van Putten","year":"2014","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib41","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm1197-1216","article-title":"Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice","volume":"3","author":"Deconinck","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng0598-79","article-title":"Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice","volume":"19","author":"Rafael","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.01.005_bib44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/mt.2008.149","article-title":"Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin\/utrophin-deficient mice","volume":"16","author":"Odom","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.mcn.2009.04.013","article-title":"The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin","volume":"41","author":"Yoon","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2019.01.005_bib46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin \u03b12 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","article-title":"Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle","volume":"7","author":"Ohlendieck","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2019.01.005_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0169-328X(02)00551-X","article-title":"Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues","volume":"109","author":"Hoyte","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ymthe.2019.01.005_bib49","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ajpath.2015.06.008","article-title":"Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice","volume":"185","author":"Xu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib50","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.082613599","article-title":"Overexpression of the cytotoxic T\u00a0cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice","volume":"99","author":"Nguyen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.01.005_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nmd.2006.12.004","article-title":"Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism","volume":"17","author":"Xu","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.01.005_bib52","doi-asserted-by":"crossref","first-page":"C476","DOI":"10.1152\/ajpcell.00456.2008","article-title":"Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice","volume":"296","author":"Martin","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","article-title":"Overexpression of the cytotoxic T\u00a0cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A","volume":"171","author":"Xu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2009.080967","article-title":"Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice","volume":"175","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib55","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","article-title":"B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I","volume":"186","author":"Thomas","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mcne.1999.0737","article-title":"Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction","volume":"13","author":"Martin","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2019.01.005_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtm.2018.06.002","article-title":"An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque","volume":"10","author":"Xu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2019.01.005_bib58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mus.21716","article-title":"Timeline of cardiac dystrophy in 3-18-month-old MDX mice","volume":"42","author":"Van Erp","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.01.005_bib59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/dbio.2001.0530","article-title":"Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression","volume":"242","author":"Xia","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib60","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.005_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.01.005_bib62","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.CIR.0000089371.11664.27","article-title":"Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart","volume":"108","author":"Yue","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.01.005_bib63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/hum.2011.017","article-title":"Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice","volume":"23","author":"Schinkel","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2353\/ajpath.2010.090479","article-title":"Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource","volume":"177","author":"Khouzami","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.01.005_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jviromet.2009.03.020","article-title":"Adeno-associated virus capsid serotype identification: Analytical methods development and application","volume":"159","author":"Van Vliet","year":"2009","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.ymthe.2019.01.005_bib66","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in\u00a0vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.005_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib68","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in\u00a0vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib70","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib71","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/mt.2008.202","article-title":"Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines","volume":"16","author":"Bish","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.005_bib72","doi-asserted-by":"crossref","first-page":"40336","DOI":"10.1038\/srep40336","article-title":"Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery","volume":"7","author":"Ai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.005_bib73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jgm.1496","article-title":"RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy","volume":"12","author":"Hu","year":"2010","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib74","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCRESAHA.116.308402","article-title":"Duchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?","volume":"118","author":"Rafael-Fortney","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.005_bib75","doi-asserted-by":"crossref","first-page":"42ra54","DOI":"10.1126\/scitranslmed.3000692","article-title":"A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy","volume":"2","author":"Chandrasekharan","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.01.005_bib76","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2019.01.005_bib77","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619300085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619300085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:12Z","timestamp":1761501192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001619300085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1525001619300085"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}